Table:
begin	end	state
1	28	non-cytoplasmic
29	52	transmembrane
53	57	cytoplasmic
58	77	transmembrane
78	95	non-cytoplasmic
96	118	transmembrane
119	126	cytoplasmic
127	147	transmembrane
148	176	non-cytoplasmic
177	198	transmembrane
199	205	cytoplasmic
206	228	transmembrane
229	275	non-cytoplasmic
276	298	transmembrane
299	316	cytoplasmic
317	338	transmembrane
339	344	non-cytoplasmic
345	365	transmembrane
366	368	cytoplasmic
369	388	transmembrane
389	406	non-cytoplasmic
407	436	transmembrane
437	573	cytoplasmic

Input:
>Pf1N1B4_2936
MSFSMPPLFAAWRQTWRAGYSLRRLRGDISAGVTVGIIAIPLAMALAIAVGVAPQQGLYT
VLIAAPLIALTGGSRFNVSGPTAAFVVILLPITQQYGLGGLLLCTMLAGAILIALGLIRA
GRLIQYIPYPVTLGFTAGIGIVIATLQLKDLLGLSTTGHAEHYIEQLGGLLQALPSARLG
DGIIGVMCLAVLIVWPRFVPRIPGHLVALAVGALLGVALESGGLAVATLGERFSYIVDGV
SHPGIPPFLPSFDWPWNLPGPYGQPLHLSYDLIRQLMAPAFAIAMLGAIESLLCAVVADG
MTGSKHDPNAELLGQGLGNLVAPLFGGITATAAIARSATNVRSGAFSPLAAIIHSAVVLL
AILALAPLFSYLPMAALAALLVMVAWNMSEARHVVHTLRIAPRSDVLVLLTCLSLTVLFD
MVLAVAVGLLLAAGLFIKRMSDLTDTAELPREFHQALEDMPEHVRCYAIRGPLFFGAAEK
ALGVLRKFSPEVKVVIVEMSAVPMLDMTALAAFDNILRDYRTDGIGLILVGTAPRVRLKL
RRAGIHREQRQLAYVNNLEQARRKSERWLVGQG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server